* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Paroxysmal movement disorders
Biology and consumer behaviour wikipedia , lookup
Copy-number variation wikipedia , lookup
History of genetic engineering wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Genome evolution wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Gene desert wikipedia , lookup
Public health genomics wikipedia , lookup
Gene expression programming wikipedia , lookup
Gene therapy wikipedia , lookup
Gene nomenclature wikipedia , lookup
Genome (book) wikipedia , lookup
Gene expression profiling wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Microevolution wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Exome sequencing wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Paroxysmal movement disorders -Paroxysmal kinesigenic dyskinesia: Triggered by sudden movement. Short-lasting and frequent. Phenytoin or carbamazepine is treatment. Associated gene: PRRT2. -Paroxysmal NON-kinesigenic dyskinesia: NOT triggered by movement, but by other triggers or at rest spontaneously. Long-lasting and infrequent. Klonopin is treatment. Associated gene: MR-1. -Paroxysmal exercise-induced dyskinesia: Triggered by SUSTAINED exercise/physical exertion. Treatment not great. Associated gene: SLC2A1. -NOTE: sometimes genes associated with one type can be seen in phenotype of another type. 1) Paroxysmal kinesigenic dyskinesia/dystonia: Pathophysiology: -Presumed channelopathy (hence its excellent response to anti-epileptics, and association with infantile convulsions) -65-75% have clear AD family history of similar symptoms, most times with complete penetrance. -Associated with PRRT-2 gene (though other genes may be involved). Signs/symptoms: -Age of onset: Average 10 years, range 1-40 years. Rare to be >18 years old. -Trigger: Sudden voluntary movement elicits the abnormal movement; other rarer triggers include anxiety/startle, intention to move/acceleration, coffee, sleep deprivation. -Aura: Tingling, odd feeling 50% of time. -Frequency: Many attacks per day (typically 1-100’s), though rarely can be as infrequent as 1-2 per year. -Duration: Average 34 seconds, VERY rarely >20 minutes. -Movement type: mixed (67%) > dystonia (17%) > chorea (15%) >ballismus (1%). Can be bilateral > unilateral. Can involve the face, sometimes associated with dysarthria. Workup -Obtain CMP and baseline MRI brain to rule out secondary causes (MS, vascular disease, tumor, etc) -May consider testing for PRRT-2 gene. Also consider whole exome sequencing. DDx: -Seizure, psychogenic, hypo/hyperglycemia, Dopa-responsive dystonia, limb shaking TIA. Dx criteria: -Identified trigger (sudden movement >>startle) + short duration (vast majority are seconds to <1 minute, though rarely can last as long as 20 minutes) + age of onset <20 (unless family hx, as some cases can start as late as age 33) + no LOC/pain during attack + normal exam in between attacks + control of attacks with carbamazepine or phenytoin. -One possible causative gene is PRRT2, but many patients have PKD without this gene, suggesting other causative genes not yet found. Tx: -Phenytoin (100-200mg daily) or carbamazepine (50-600mg daily); often responds quite well (85% are responders) to even low doses. Some suggestion that Diamox or Topamax may also be helpful. -Prognosis: 25% remit spontaneously; another 25% had marked improvement with time (ie, by age 30) 2) Paroxysmal NON-kinesigenic dyskinesia/dystonia: Pathophysiology: -AD, with high penetrance. -Due to mutation in MR-1 gene. Consider whole exome sequencing. Signs/symptoms: -Age of onset: Mean 5 years, range 6 months to 35 years (RARE to have onset > age 18) -Trigger: NOT movement; classically alcohol, caffeine, or strong emotion/stress that elicits the abnormal movement, though sometimes may have no clear trigger at all. -Aura: Sometimes present. Tightness in a limb, odd mouth movements, SOB, migraine, or anxiety. -Frequency: Few times a year (though can cluster a few times in a week); most (77%) report at least 1 attack/week. -Duration: Usually last 10-60 minutes, but can last up to 12 hours; rarely < 1 minute. -Movement Type: dystonia AND chorea (65%); less commonly dystonia (27%) or chorea (2.7%) by itself. Can involve face. May be associated with dysarthria/anarthria with retained awareness. Workup -Obtain CMP and baseline MRI brain to rule out secondary causes (MS, vascular disease, tumor, etc) -May consider gene testing for MR-1. DDx: -Psychogenic, Dopa-responsive dystonia, seizure. Tx: -Avoid triggers -Klonopin is treatment of choice (80-90% of patients had good response) -Anti-epileptics are not effective 3) Paroxysmal exercise-induced dyskinesias/dystonia: Pathophysiology: -Extremely rare, only about 30 reported cases. -Can associated with epilepsy -Associated with gene SCL2A1 (though other genes may also be the culprit). Consider whole exome sequencing. Signs/symptoms: -Age of onset: mean of 8.6 years old, range 1-49 years old, but RARE to have onset >age 18 years. -Trigger: Sustained exertion, usually lasting 5-15 minutes; more rare triggers are fasting, stress, or anxiety. -Aura: None -Frequency: Usually several attacks per week. -Duration: Mean 15-40 minutes (can last up to several hours, very rare to last less than 5 minutes). Resolve within 10 minutes of stopping exercise. -Movement types: Almost always mixed dystonia-chorea (95%). Can be associated with migraines or epilepsy or ataxia. Workup -Obtain CMP and baseline MRI brain to rule out secondary causes (MS, vascular disease, tumor, etc) -May consider gene testing for SLC2A1. DDx: -Psychogenic, Dopa-responsive dystonia, seizure. Tx: -Antiepileptics don’t work well, aside from maybe gabapentin -Some evidence for ketogenic diet Gene-testing algorithm: Review articles: 1) Bhatia, Kailash P. "Paroxysmal dyskinesias." Movement Disorders 26.6 (2011): 1157-1165. 2) Erro, Roberto, Una‐Marie Sheerin, and Kailash P. Bhatia. "Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification." Movement Disorders 29.9 (2014): 1108-1116.